Literature DB >> 11825997

Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groups.

Nicholas M Anstey1, Bart J Currie, Marilyn Hassell, Didier Palmer, Brian Dwyer, Harald Seifert.   

Abstract

Acinetobacter isolates from eight subjects with community-acquired Acinetobacter pneumonia (CAAP), a major cause of fatal community-acquired pneumonia in tropical Australia, were phenotypically and genotypically confirmed by pulsed-field gel electrophoresis analysis to be broadly diverse Acinetobacter baumannii strains. Wet-season throat carriage of A. baumannii was found in 10% of community residents with excess levels of alcohol consumption, the major at-risk group for CAAP.

Entities:  

Mesh：

Year:  2002        PMID： 11825997      PMCID： PMC153418          DOI： 10.1128/JCM.40.2.685-686.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  9 in total

1.  Skin carriage of acinetobacters in Hong Kong.

Authors:  Y W Chu; C M Leung; E T Houang; K C Ng; C B Leung; H Y Leung; A F Cheng
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

2.  Acinetobacter bacteremia in the tropics.

Authors:  H Seifert
Journal:  Clin Infect Dis       Date:  1999-01       Impact factor: 9.079

3.  Community-acquired Acinetobacter pneumonia in the Northern Territory of Australia.

Authors:  N M Anstey; B J Currie; K M Withnall
Journal:  Clin Infect Dis       Date:  1992-01       Impact factor: 9.079

4.  Interspecies transformation of Acinetobacter: genetic evidence for a ubiquitous genus.

Authors:  E Juni
Journal:  J Bacteriol       Date:  1972-11       Impact factor: 3.490

5.  Epidemiology and infection control implications of Acinetobacter spp. in Hong Kong.

Authors:  E T Houang; Y W Chu; C M Leung; K Y Chu; J Berlau; K C Ng; A F Cheng
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

6.  Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods.

Authors:  H Seifert; L Dijkshoorn; P Gerner-Smidt; N Pelzer; I Tjernberg; M Vaneechoutte
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

7.  Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis.

Authors:  M Vaneechoutte; L Dijkshoorn; I Tjernberg; A Elaichouni; P de Vos; G Claeys; G Verschraegen
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

8.  Plasmid DNA fingerprinting of Acinetobacter species other than Acinetobacter baumannii.

Authors:  H Seifert; A Schulze; R Baginski; G Pulverer
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

9.  Identification and biotyping of clinical isolates of Acinetobacter.

Authors:  P J Bouvet; P A Grimont
Journal:  Ann Inst Pasteur Microbiol       Date:  1987 Sep-Oct
  9 in total
  33 in total

1.  The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor.

Authors:  Thomas A Russo; Nicole R Luke; Janet M Beanan; Ruth Olson; Shauna L Sauberan; Ulrike MacDonald; L Wayne Schultz; Timothy C Umland; Anthony A Campagnari
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

Review 2.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors:  Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

3.  Characterization of a cyclophosphamide-induced murine model of immunosuppression to study Acinetobacter baumannii pathogenesis.

Authors:  Swetha Manepalli; Jay A Gandhi; Vaibhav V Ekhar; Melissa B Asplund; Carolina Coelho; Luis R Martinez
Journal:  J Med Microbiol       Date:  2013-09-02       Impact factor: 2.472

4.  Acinetobacter bacteraemia in Thailand: evidence for infections outside the hospital setting.

Authors:  K A Porter; J Rhodes; S Dejsirilert; S Henchaichon; D Siludjai; S Thamthitiwat; P Prapasiri; P Jorakate; A Kaewpan; L F Peruski; A Kerdsin; K Prasert; S Yuenprakone; S A Maloney; H C Baggett
Journal:  Epidemiol Infect       Date:  2013-09-04       Impact factor: 2.451

5.  The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization.

Authors:  Thomas A Russo; Janet M Beanan; Ruth Olson; Ulrike MacDonald; Andrew D Cox; Frank St Michael; Evgeny V Vinogradov; Brad Spellberg; Nicole R Luke-Marshall; Anthony A Campagnari
Journal:  Infect Immun       Date:  2013-01-07       Impact factor: 3.441

6.  Molecular mechanisms of ethanol-induced pathogenesis revealed by RNA-sequencing.

Authors:  Laura Camarena; Vincent Bruno; Ghia Euskirchen; Sebastian Poggio; Michael Snyder
Journal:  PLoS Pathog       Date:  2010-04-01       Impact factor: 6.823

7.  Acquisition of a High Diversity of Bacteria during the Hajj Pilgrimage, Including Acinetobacter baumannii with blaOXA-72 and Escherichia coli with blaNDM-5 Carbapenemase Genes.

Authors:  Thongpan Leangapichart; Philippe Gautret; Karolina Griffiths; Khadidja Belhouchat; Ziad Memish; Didier Raoult; Jean-Marc Rolain
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

8.  Synergistic effects and antibiofilm properties of chimeric peptides against multidrug-resistant Acinetobacter baumannii strains.

Authors:  Ramamourthy Gopal; Young Gwon Kim; Jun Ho Lee; Seog Ki Lee; Jeong Don Chae; Byoung Kwan Son; Chang Ho Seo; Yoonkyung Park
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

Review 9.  Acinetobacter infections: a growing threat for critically ill patients.

Authors:  M E Falagas; E A Karveli; I I Siempos; K Z Vardakas
Journal:  Epidemiol Infect       Date:  2007-09-25       Impact factor: 2.451

Review 10.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.